A peptic ulcer, diagnosed in 1964, had responded to medical management ... The development of myasthenia gravis ten years after detection of thymoma 18 and four and a half years after thymectomy ...

Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset, thymoma, ocular, anti-MuSK, anti-LRP4 and antibody-negative MG. MG has a prevalence of 140 per million, and an annual ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

In most cases, the first step in altering the course of myasthenia gravis is surgical removal of the thymus gland (thymectomy). The thymus gland is located behind the sternum (breastbone) and is ...

We have some surgeries. The surgery that is used in the treatment of myasthenia gravis is a thymectomy or removal of the thymus gland. The thymus gland is a gland that's involved in our autoimmune ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

Myasthenia gravis (MG) should be subgrouped into early-onset, late-onset, thymoma, ocular, anti-MuSK, anti-LRP4 and antibody-negative MG. MG has a prevalence of 140 per million, and an annual ...

Hohlfeld R, Melms A, Schneider C, Toyka KV, Drachman DB: Therapy of myasthenia gravis and myasthenic syndromes ... Müller-Hermelink HK: Thymoma and thymic carcinoma: an update of the WHO ...